Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Role of neuropeptide Y and proopiomelanocortin in fluoxetine-induced anorexia

  • 70 Accesses

  • 17 Citations

Abstract

Fluoxetine is an anorexic agent known to reduce food intake and weight gain. However, the molecular mechanism by which fluoxetine induces anorexia has not been well-established. We examined mRNA expression levels of neuropeptide Y (NPY) and proopiomelanocortin (POMC) in the brain regions of rats using RT-PCR andin situ hybridization techniques after 2 weeks of administering fluoxetine daily. Fluoxetine persistently suppressed food intake and weight gain during the experimental period. The pair-fed group confirmed that the reduction in body weight in the fluoxetine treated rats resulted primarily from decreased food intake. RT-PCR analyses showed that mRNA expression levels of both NPY and POMC were markedly reduced by fluoxetine treatment in all parts of the brain examined, including the hypothalamus. POMC mRNAin situ signals were significantly decreased, NPY levels tended to increase in the arcuate nucleus (ARC) of fluoxetine treated rats (compared to the vehicle controls). In the pair-fed group, NPY mRNA levels did not change, but the POMC levels decreased (compared with the vehicle controls). These results reveal that the chronic administration of fluoxetine decreases expression levles in both NPY and POMC in the brain, and suggests that fluoxetine-induced anorexia may not be mediated by changes in the ARC expression of either NPY or POMC. It is possible that a fluoxetine raised level of 5-HT play an inhibitory role in the orectic action caused by a reduced expression of ARC POMC (α-MSH).

This is a preview of subscription content, log in to check access.

References

  1. Anelli, M., Bizzi, A., Caccia, S., Codegoni, A. M., Fracasso, C., and Garattini, S., Anorectic activity of fluoxetine and norfluoxetine in mice, rats, and guinea-pigs.J. Pharm. Pharmacol., 44, 696–698 (1992).

  2. Badawy, A. A. B., Morgan, C. J., Bano, S., Buckland, P., and McGuffin, P., Mechanism of enhancement of rat brain serotonin synthesis by acute fluoxetine administration.J. Neurochem., 66, 436–437 (1996).

  3. Baker, R. A., Herkenham, M., and Brady, L. S., Effects of longterm treatment with antidepressant drugs on proopiomelanocortin and neuropeptide Y mRNA expression in the hypothalamic arcuate nucleus of rats.J. Neuroendocrinol., 8, 337–343 (1996).

  4. Bernardis, L. L. and Bellinger, L. L., The lateral hypothalamic area revisited: ingestive behavior.Neurosci. Biobehav. Rev., 20, 189–287 (1996).

  5. Dryden, S., Frankish, H. M., Wang, Q., and Williams, G., Increased feeding and neuropeptide Y (NPY) but not NPY mRNA levels in the hypothalamus of the rat following central administration of the serotonin synthesis inhibitorp-chlorophenylalanine.Brain Res., 724, 232–237 (1996).

  6. Gutierrez, A., Saracibar, G., Casis, L., Echevarria, E., Rodriguez, V. M., Macarulla, M. T., Abecia, L. C., and Portillo, M. P., Effects of fluoxetine administration on neuropeptide Y and orexins in obese Zucker rat hypothalamus.Obesity Res., 10, 532–539 (2002).

  7. Hervas, I. and Artigas, F., Regional effects of fluoxetine on extracellular 5-HT in DRN-and MRN-innervated areas of the rat brain.J. Neurochem., 66, S36 (1996).

  8. Jahng, W. W., Houpt, T. A., Joh, T. H., and Son, J. H., Differential expression of monoamine oxidase A, serotonin transporter, tyrosine hydroxylase and norepinephrine transporter mRNA by anorexia mutation and food deprivation.Dev. Brain Res., 107, 241–246 (1998).

  9. Kim, E. M., Welch, C. C., Grace, M. K., Billington, C. J., and Levine, A. S., Chronic food restriction and acute food deprivation decrease mRNA levels of opioid peptides in arcuate nucleus.Am. J. Physiol., 270(5 Pt2), R1019-R1024 (1996).

  10. Kim, E.-M., Grace, M. K., O'Hare, E., Billington, C. J., and Levine, A. S., Injection of α-MSH, but not β-endorphin, into the PVN decreases POMC gene expression in the ARC.Neuroreport, 13, 497–500 (2002).

  11. Kristensen, P., Judge, M. E., Thim, L., Ribel, U., Christjansen, K. N., Wulff, B. S., Clausen, J. T., Jensen, P. B., Madsen, O. D., Vrang, N., Larsen, P. J., and Hastrup, S., Hypothalamic CART is a new anorectic peptide regulated by leptin.Nature, 393, 72–76 (1998).

  12. Le Feuvre, R. A., Aisenthal, L., and Rothwell, N. J., Involvement of corticotrophin releasing factor (CRF) in the thermogenic and anorexic actions of serotonin (5-HT) and related compounds.Brain Res., 555, 245–250 (1991).

  13. Leibowitz, S. F., Weiss, G. F., and Suh, J., Medial hypothalamic nuclei mediate serotonin's inhibitory effect on feeding behavior.Pharmacol. Biochem. Behav., 37, 735–742 (1990).

  14. Marsh, D. J., Hollopeter, G., Huszar, D., Laufer, R., Yagaloff, K. A., Fisher, S. L., Burn, P., and Palmiter, R. D., Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides.Nature Genet., 21, 119–122 (1999).

  15. Mizuno, T. M., Kleopoulos, S. P., Bergen, H. T., Roberts, J. L., Priest, C. A., and Mobbs, C. V., Hypothalamic pro-opiomel-anocortin mRNA is reduced by fasting inob/ob anddb/db mice, but is stimulated by leptin.Diabetes, 47, 294–297 (1998).

  16. Muck-Seler, D., Jevric-Causevic, A., and Diksic, M., Influence of fluoxetine on regional serotonin synthesis in the rat brain.J. Neurochem., 67, 2434–2442 (1996).

  17. Ollmann, M. M., Wilson, B. D., Yang, Y. K., Kerns, J. A., Chen, Y., Gantz, I., and Barsh, G. S., Antagonism of central melanocortin receptorsin vitro andin vivo by agouti-related protein.Science, 278, 135–138 (1997).

  18. Paxions, G. and Watson, C.,The Rat Brain in Stereotaxic Coordinate. San Diego, CA, Academic Press (1986).

  19. Pollock, J. D. and Rowland, N., Peripherally administered serotonin decreased food intake in rats.Pharmacol. Biochem. Behav., 15, 179–183 (1981).

  20. Rang, H. P., Dale, M. M., Ritter, J. M., and Moore, P. K., Obesity. In Rang, H. P., Dale, M. M., J. M. Ritter, & P. K. Moore (Eds.),Pharmacology (pp. 394–403). Oxford: Churchill Livingstone (2003).

  21. Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., Arch, J. R., Buckingham, R. E., Haynes, A. C., Carr, S. A., Annan, R. S., McNulty, D. E., Liu, W. S., Terrett, J. A., Elshourbagy, N. A., Bergsma, D. J., and Yanagisawa, M., Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.Cell, 92, 573–585 (1998).

  22. Schwartz, M. W., Seeley, R. J., Woods, S. C., Weigle, D. S., Campfield, L. A., Burn, P., and Baskin, D. G., Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus.Diabetes, 46, 2119–2123 (1997).

  23. Weiss, G. F., Rogacki, N., Fueg, A., Buchen, D., Suh, J. S., Wong, D. T., and Leibowitz, S. F., Effect of hypothalamic and peripheral fluoxetine injection on natural patterns of macronutrient intake in the rat.Psychopharmacology, 105, 467–476 (1991).

  24. Wolf, G., Neuropeptides responding to leptin.Nutr. Rev., 55, 85–88 (1997).

  25. Yaswen, L., Diehl, N., Brennan, M. B., and Hochgeschwender, U., Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin.Nature Med., 5, 1066–1070 (1999).

Download references

Author information

Correspondence to Chang-Seon Myung.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Myung, C., Kim, B., Choi, S.H. et al. Role of neuropeptide Y and proopiomelanocortin in fluoxetine-induced anorexia. Arch Pharm Res 28, 716–721 (2005). https://doi.org/10.1007/BF02969363

Download citation

Key words

  • Fluoxetine
  • Neuropeptide Y
  • Proopiomelanocortin
  • Hypothalamus
  • Rats
  • Anorexia